Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial

OBJECTIVE: To evaluate the safety and efficacy of ospemifene for the treatment of moderate to severe vaginal dryness in postmenopausal women with vulvovaginal atrophy (VVA). METHODS: This 12-week, multicenter, double-blind phase 3 study randomized postmenopausal women (aged 40-80 years) with VVA and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Menopause
Auteurs principaux: Archer, David F., Goldstein, Steven R., Simon, James A., Waldbaum, Arthur S., Sussman, Steven A., Altomare, Corrado, Zhu, Julie, Yoshida, Yuki, Schaffer, Sam, Soulban, Graziella
Format: Artigo
Langue:Inglês
Publié: Lippincott-Raven Publishers 2019
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553508/
https://ncbi.nlm.nih.gov/pubmed/30694917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000001292
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires